INMB
INmune Bio (INMB)
$43
About INmune Bio (INMB)
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
Details
Daily high
$1.50
Daily low
$1.41
Price at open
$1.41
52 Week High
$11.64
52 Week Low
$1.09
Market cap
38.0M
Dividend yield
0.00%
Volume
240,373
Avg. volume
249,627
P/E ratio
-.74
INmune Bio News
Details
Daily high
$1.50
Daily low
$1.41
Price at open
$1.41
52 Week High
$11.64
52 Week Low
$1.09
Market cap
38.0M
Dividend yield
0.00%
Volume
240,373
Avg. volume
249,627
P/E ratio
-.74